We invite physicians, APPs, and nurses to join us Wed. April 8 at 6pm for a free networking and CME dinner on women's health and #breastcancer. ➡️Presenters: Drs. @maryamlustberg.bsky.social, Daniel O'Neil, Johanna D'Addario, Sharon Hall, + Ashita Talsania! ➡️RSVP bit.ly/4sVlvCX

Thank you to the presenters and attendees at our inaugural #AI in #Cancer Workshop—highlighting how AI is advancing early detection and enabling more personalized cancer care. A day filled with valuable insights & new collaborations. @williamohmd.bsky.social @maryamlustberg.bsky.social

Join us Wednesday, Jan. 28 at 6pm for a free networking and #CME dinner on women's health + #breastcancer. Presenters include Drs. Robert Legare, Anca Bulgaru, Mary Jane Minkin, Jill Banatoski, and @maryamlustberg.bsky.social. ➡️RSVP bit.ly/48QFOcc

Ismail Ajjawi @yaleschoolofmed.bsky.social ’27 presents data on premenopausal women with early-stage HR+/HER2– node-negative #breastcancer at #SABCS25 • Chemo use ⬇️ 35%→24% • 72% omitted chemo, w/no difference in 5-yr OS @oncoalert.bsky.social @sabcs.bsky.social @maryamlustberg.bsky.social

Drs. Jessica Liu and Guannan Gong present new data #SABCS25 showing automated #ClinicalTrial Patient Matching (CTPM) helps identify diverse trial candidates, but additional strategies are needed to boost participation. @maryamlustberg.bsky.social

@maryamlustberg.bsky.social presents #REPOWER at #SABCS25 —an intl study of pts with stage II/III HR+/HER2- early #breastcancer receiving adjuvant ribociclib + endocrine therapy. @oncoalert.bsky.social @sabcs.bsky.social

📌Starting #SABCS25 off with a discussion of the Advanced Breast Cancer (ABC) Global Decade Report 📈 🔸improved 5 year OS 26% ➡️33% 🔸improvement in QOL, but 79% report negative QOL 🔸access to care gaps have widened ✅ 10 goals 2025-2035 #bcsm @maryamlustberg.bsky.social

This afternoon at 2:30pm CST/3:30pm EST #SABCS25, @maryamlustberg.bsky.social shares two presentations during Education Session 4: Hormone Replacement Therapy in #BreastCancer Care. sabcs.org/events/educa... @sabcs.bsky.social

@maryamlustberg.bsky.social highlights the major unmet needs in #menopause care after #breastcancer at #SABCS25. “Our patients have a lot of symptoms and they are not always being addressed — we need to do a lot better.” @sabcs.bsky.social

Important conversation at #SABCS25 on hormone replacement therapy in breast cancer care with Drs. @lisalarkinmd.bsky.social, Jewel King, Thelma Brown, @maryamlustberg.bsky.social, and Tara Sanft. @theaacr.bsky.social @sabcs.bsky.social

@maryamlustberg.bsky.social breaks down key insights on hormone replacement therapy #HRT for #breastcancer survivors at #SABCS25: "We are not the hormone police—our role is to empower patients." @sabcs.bsky.social

@maryamlustberg.bsky.social highlights why patient-reported outcomes (PROs) must be central to oncology drug development and clinical trials at #SABCS25: "Partnering with our patients and patient advocacy organizations is the path forward." @sabcs.bsky.social

15 Posts Not to Miss from SABCS 2025, Part 1 @sabcs.bsky.social @drsgraff.bsky.social @ptarantinomd.bsky.social @stage4kelly.bsky.social @maryamlustberg.bsky.social oncodaily.com/not-to-miss/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SABCS #SABCS25 #SABCS2025

Dr. Guannan Gong shares how an #AI-driven patient-matching system improved ID of eligible patients for #breastcancer trials + increased representation of under-enrolled groups. #SABCS25 @maryamlustberg.bsky.social @sabcs.bsky.social @oncoalert.bsky.social

Powerful message from Dr. Amy Beumer at #SABCS25: It’s time to “fix the toxic friendship” and design dosing with patients—balancing side effects, quality of life, and longevity. @maryamlustberg.bsky.social @sabcs.bsky.social

Balancing Act: Hormone Replacement Therapy in Breast Cancer Care— Maryam Lustberg, Juliana Kling, Lisa Larkin, & advocate Thelma P. Brown addressed this topic in an #SABCS25 educational session moderated by Tana Sanft. @maryamlustberg.bsky.social @lisalarkinmd.bsky.social @drjewelk.bsky.social

The editors of @ascocancer.bsky.social's #JCOOncologyAdvances recently met at the ASCO HQ to discuss strategy and planning for the year ahead. @pamelakunzmd.bsky.social serves as editor-in-chief and she was joined by associate editors, including Yale’s @maryamlustberg.bsky.social.

@maryamlustberg.bsky.social shares insights on #breastcancer prevention, treatment, and new research, in honor of #breastcancerawarenessmonth tonight at 7:30pm on #YaleCancerAnswers. 🎧Listen live on WNPR 🔁Download on Apple Podcasts 💻Watch on YouTube

Thank you to everyone that joined us Wednesday night at the #SaybrookResortandMarina for an evening of networking and connections around the topic of #womenshealth! @maryamlustberg.bsky.social

We’re hosting a webinar for members on “Centering Voices: Best Practices for Engaging People with Lived Experience in Supportive Care in Cancer”. Registration is open to all members. To become a member, click here: mascc.org/join-mascc/ #SuppOnc @maryamlustberg.bsky.social @coffeemommy.bsky.social

ABC Global Alliance - Maryam Lustberg on Supportive and Oncological Care at ABC8 @maryamlustberg.bsky.social oncodaily.com/voices/marya... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

An empowering + emotional day at our Caring for Metastatic Breast Cancer conference on Saturday. 💗 From groundbreaking research to personal stories of strength, we're reminded: no one faces #MBC alone. #BreastFriendsFund @maryamlustberg.bsky.social

In metastatic #breastcancer, sacituzumab govitecan given after trastuzumab deruxtecan was linked to ⬇️ PFS across all subtypes. Real-world data published in #JNCI show differences in outcomes by type. academic.oup.com/jnci/advance... @maryamlustberg.bsky.social

A big thank you once again to our dedicated Social Media Ambassadors for 2025: @maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social Thank you for your insightful posting across the three days of #MASCC25!

Thank you!

Congratulations to @maryamlustberg.bsky.social named an inaugural @cancercaremascc.bsky.social Fellow during #mascc25!

Really appreciated the invite to speak from #MASCC25 and @maryamlustberg.bsky.social What a great conference! Amazing speakers on the #toxicities panel. #supportivecarematters #CanSky #OncoSky #IDSky

MASCC Introduced MASCC 2025 Social Media Ambassadors @cancercaremascc.bsky.social @darcyburbage.bsky.social @maryamlustberg.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social @coffeemommy.bsky.social oncodaily.com/blog/mascc-2... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd

Kudos and gratitude to the organizers, attendees, and fellow faculty members for today's Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment #MASCC25 @maryamlustberg.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @brueraeduardo.bsky.social

Grateful for the insights and discussions shared with the stellar panelists and engaged audience at #MASCC25 workshop for cancer treatment toxicities. @maryamlustberg.bsky.social @ericroeland.bsky.social @coffeemommy.bsky.social and Dr Eduardo Bruera with screenshot from @stage4kelly.bsky.social

Introducing our #MASCC25 Social Media Ambassadors on Bluesky! Follow them for daily highlights from across our scientific program: @maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social

Dr. Melissa Taylor presents data demonstrating the positive impact of ReX, a remote digital nurse app, to ⬇️ medication discontinuation and track #PROs at #ASCO25. meetings.asco.org/abstracts-pr... @maryamlustberg.bsky.social @oncoalert.bsky.social @yaleschoolofmed.bsky.social

@michael-jefford.bsky.social champions an allstar #survonc panel. 20 years from #IOM paper Lost in Transition. So much ground covered, so much yet to go. @oncoalert.bsky.social @weoncologists.bsky.social @pallonccop.bsky.social @fumikochino.bsky.social @maryamlustberg.bsky.social

Inspirational words on positioning yourself for success by these four women physician leaders! Sharing advice with early career women in oncology. Now we have the tools for success🛠️✨#ASCO2025 @maryamlustberg.bsky.social @drgattimays.bsky.social @yalecancer.bsky.social

Join us to discuss patient partnering in managing chronic toxicities of cancer treatment -with increasing burden from newer regimes on patients, doctors, and our healthcare systems. #medsky #palliative #supportivecare #oncosky #cancer #toxicities

1/2 Don’t miss our #MASCC25 workshop “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment”, chaired by @maryamlustberg.bsky.social & @tingtingzhang.bsky.social With presentations from @ericroeland.bsky.social @brueraeduardo.bsky.social and @coffeemommy.bsky.social

Thank you @maryamlustberg.bsky.social for sharing updates from @cancercaremascc.bsky.social to the @pallonccop.bsky.social !! Looking forward to participating/promoting the many great programs and initiatives! #oncsky #oncologynursing

“Both hand cooling and compression were effective in preventing sensory #CIPN during taxane-based chemotherapy” #oncsky #oncologynursing @pallonccop.bsky.social @oncoalert.bsky.social jamanetwork.com/journals/jam...

We're heading to Chicago for the @theaacr.bsky.social Annual Meeting #AACR25! Follow along as we share highlights and news throughout the meeting. yalecancercenter.org/news-article... @yaleschoolofmed.bsky.social

A @yalecancer.bsky.social -led study examined chemotherapy-induced peripheral neuropathy #CIPN from clinical presentation, risk factors, + treatment strategies to impact of CIPN on QOL + patient experience. apm.amegroups.org/article/view... @yaleschoolofmed.bsky.social @maryamlustberg.bsky.social

Watch the recording from our recent webinar: Innovative Approaches in the Management of Bone Metastasis: Enhancing Patient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs) Prevention, and Biosimilars vimeo.com/1071779724?s... #SuppOnc @fatmabenabid.bsky.social

One week left to register for #MASCC25 at the early bird rate! The deadline is April 23, so be sure to register soon to take advantage of the discounted price. mascc.org/annualmeetin... #OncSky @oncoalert.bsky.social @maryamlustberg.bsky.social @andreasc.bsky.social @joannebowen.bsky.social

It's my first time going to @cancercaremascc.bsky.social!! Honored to be invited to speak about #financialToxicity and excited to see all of the amazing work being done in #supponc #survonc #pallonc 📆Register by 4/23/2025 to take advantage of the reduced "early bird" price for #MASCC25

The early bird registration deadline is coming up soon! Register by April 23, 2025 to take advantage of the reduced price for #MASCC25 mascc.org/annualmeetin... @oncoalert.bsky.social #OncSky @maryamlustberg.bsky.social @joannebowen.bsky.social @andreasc.bsky.social

Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early #BreastCancer, a discrete choice survey study recently published in the Breast Cancer Research and Treatment journal. 🔓https://pubmed.ncbi.nlm.nih.gov/39915434/ @elmayermd.bsky.social @maryamlustberg.bsky.social

Sounds like a great session @maryamlustberg.bsky.social!

Oncology HERE & NOW Webcast/Podcast Now Out, JOIN OncoAlert Faulty🚨 Dr. @elisaagostinetto.bsky.social 🇧🇪& Dr. @maryamlustberg.bsky.social 🇺🇸 as they dive into #BreastCancer and the use of adj CDK 4/6 inhibitors and more youtu.be/zw8vYd894jI Podcasts : buzzsprout.com/1324033/epis...

Congratulations to @craigmcrews.bsky.social, recipient of the 2025 Passano Award for his work leading to a new class of drugs—the #PROTAC concept—targeting protein degradation to treat #cancer and human diseases. @yaleschoolofmed.bsky.social

Thank you Infinite Strength & Roberta Lombardi for this wonderful conference #mbc #bcsm

One week left to submit your late-breaker abstracts for #MASCC25! Original research that has been completed after the regular abstract submission deadline is eligible for submission by March 12. mascc.org/annualmeetin... @oncoalert.bsky.social @joannebowen.bsky.social @maryamlustberg.bsky.social